160 related articles for article (PubMed ID: 27456692)
1. The reporting and diagnosis of uterine fibroids in the UK: an observational study.
Martín-Merino E; Wallander MA; Andersson S; Soriano-Gabarró M; Rodríguez LA
BMC Womens Health; 2016 Jul; 16():45. PubMed ID: 27456692
[TBL] [Abstract][Full Text] [Related]
2. The incidence of hysterectomy, uterus-preserving procedures and recurrent treatment in the management of uterine fibroids.
Martín-Merino E; García Rodríguez LA; Wallander MA; Andersson S; Soriano-Gabarró M
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():147-52. PubMed ID: 26407334
[TBL] [Abstract][Full Text] [Related]
3. Burden of symptomatic uterine fibroids in Canadian women: a cohort study.
Laberge PY; Vilos GA; Vilos AG; Janiszewski PM
Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364
[TBL] [Abstract][Full Text] [Related]
4. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey.
Soliman AM; Margolis MK; Castelli-Haley J; Fuldeore MJ; Owens CD; Coyne KS
Curr Med Res Opin; 2017 Nov; 33(11):1971-1978. PubMed ID: 28836862
[TBL] [Abstract][Full Text] [Related]
5. Treatment Patterns in Patients with Uterine Fibroids With and Without a Diagnosis of Heavy Menstrual Bleeding: Results from a Large U.S. Claims Database.
McKain L; Edsall K; Dufour R; Lickert C
J Womens Health (Larchmt); 2023 Mar; 32(3):332-340. PubMed ID: 36413048
[No Abstract] [Full Text] [Related]
6. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
7. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
8. Uterine Fibroids, Perceived Stress, and Menstrual Distress: a Key Role of Heavy Menstrual Bleeding.
Vannuccini S; Clemenza S; Cassioli E; Rossi E; Castellini G; Ricca V; Petraglia F
Reprod Sci; 2023 May; 30(5):1608-1615. PubMed ID: 36471219
[TBL] [Abstract][Full Text] [Related]
9. The association between occupational characteristics and hysterectomies for treating uterine fibroids in Taiwan.
Ho YL; Hung CJ; Lin CC; Liu CC; Li CS; Kao CH
Women Health; 2015; 55(1):77-89. PubMed ID: 25531280
[TBL] [Abstract][Full Text] [Related]
10. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire.
Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K
Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082
[TBL] [Abstract][Full Text] [Related]
11. Association between breast diseases and symptomatic uterine fibroids by using South Korean National Health Insurance database.
Yuk JS; Yang SW; Yoon SH; Kim MH; Seo YS; Lee Y; Joo Y; Kim J; Yoon SY; Cho H; Yang K; Gwak G
Sci Rep; 2023 Oct; 13(1):16772. PubMed ID: 37798304
[TBL] [Abstract][Full Text] [Related]
12. Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid.
Oderda G; Asche C; Jones KP; Merrill RM; Spalding J
Arch Gynecol Obstet; 2007 Sep; 276(3):211-8. PubMed ID: 17342498
[TBL] [Abstract][Full Text] [Related]
13. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
14. Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language.
Oliveira Brito LG; Malzone-Lott DA; Sandoval Fagundes MF; Magnani PS; Fernandes Arouca MA; Poli-Neto OB; Nogueira AA
Sao Paulo Med J; 2017; 135(2):107-115. PubMed ID: 28301630
[TBL] [Abstract][Full Text] [Related]
15. Contemporary management of uterine fibroids: focus on emerging medical treatments.
Singh SS; Belland L
Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
[TBL] [Abstract][Full Text] [Related]
16. Describing the Patient Journey of Women with Claims for Uterine Fibroids and Heavy Menstrual Bleeding Using a Commercial Database (2011-2020).
Agarwal SK; Stokes M; Kung T; Tilney R; Lickert C
Int J Womens Health; 2023; 15():1561-1575. PubMed ID: 37867928
[TBL] [Abstract][Full Text] [Related]
17. Anxiety, Depression, and Quality of Life After Procedural Intervention for Uterine Fibroids.
Wallace K; Stewart EA; Wise LA; Nicholson WK; Parry JP; Zhang S; Laughlin-Tommaso S; Jacoby V; Anchan RM; Diamond MP; Venable S; Shiflett A; Wegienka GR; Maxwell GL; Wojdyla D; Myers ER; Marsh E
J Womens Health (Larchmt); 2022 Mar; 31(3):415-424. PubMed ID: 34101502
[No Abstract] [Full Text] [Related]
18. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial.
de Bruijn AM; Ankum WM; Reekers JA; Birnie E; van der Kooij SM; Volkers NA; Hehenkamp WJ
Am J Obstet Gynecol; 2016 Dec; 215(6):745.e1-745.e12. PubMed ID: 27393268
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.
Zimmermann A; Bernuit D; Gerlinger C; Schaefers M; Geppert K
BMC Womens Health; 2012 Mar; 12():6. PubMed ID: 22448610
[TBL] [Abstract][Full Text] [Related]
20. Health Care Costs and Treatment Patterns Associated with Uterine Fibroids and Heavy Menstrual Bleeding: A Claims Analysis.
Wang A; Wang S; Owens CD; Vora JB; Diamond MP
J Womens Health (Larchmt); 2022 Jun; 31(6):856-863. PubMed ID: 34591695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
